Patents by Inventor Mark K. Sloan
Mark K. Sloan has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Publication number: 20240366121Abstract: Methods, apparatuses, and systems are provided for determining whether to administer a medication dose as a single dose or whether to fractionate the single dose to be administered as at least two discrete doses. Embodiments include determining a first analyte level and a first rate of change of the analyte level; determining an initial medication dose based on one or more anticipated subsequent medication doses, the first analyte level relative to an analyte level threshold, and the first rate of change of the analyte level relative to a rate of change threshold; administering the initial medication dose; determining a second analyte level and a second rate of change of the analyte level based on subsequent analyte data; and determining a subsequent medication dose based on the second analyte level relative to the analyte level threshold and the second rate of change relative to the rate of change threshold.Type: ApplicationFiled: July 5, 2024Publication date: November 7, 2024Inventors: Mark K. SLOAN, Martin J. FENNELL, Daniel M. BERNSTEIN
-
Publication number: 20240214114Abstract: Disclosed herein are methods and systems for receiving an encoded data packet, one or more activation commands, and a communication identifier, decoding the received data packet, validating the decoded received data packet, and executing one or more routines associated with the respective one or more activation commands.Type: ApplicationFiled: August 1, 2023Publication date: June 27, 2024Inventors: Jeffery M. Sicurello, Mark K. Sloan
-
Publication number: 20240201775Abstract: Methods and articles of manufacture for hosting a safety critical application on an uncontrolled data processing device are provided. Various checks and combinations of checks including installation, functional, host integrity, coexistence, interoperability, power management, and environment checks are performed at various times to determine if the safety critical application operates properly on the device. The operation of the SCA on the UDPD may be controlled accordingly.Type: ApplicationFiled: January 23, 2024Publication date: June 20, 2024Inventors: Daniel M. BERNSTEIN, Saeed NEKOOMARAM, Mark K. SLOAN
-
Publication number: 20230346269Abstract: Methods of compensating for ambient temperature using temperature sensors, the method comprising: sampling at a first sampling rate, with a processor, first temperature measurements from a first temperature sensor on an on-body sensor. Then determining, with a processor, first ambient-compensated temperatures from the first temperature measurements; and determining, with a processor, final ambient-compensated temperatures by applying a correction gain or factor to the first ambient-compensated temperatures. Wherein the correction gain or factor changes value at a slower rate than the sampling rate.Type: ApplicationFiled: June 23, 2023Publication date: November 2, 2023Applicant: Abbott Diabetes Care Inc.Inventors: Gary A. HAYTER, Daniel M. BERNSTEIN, Martin J. FENNELL, Michael R. LOVE, Kenneth J. DONIGER, Songbiao ZHANG, Mark K. SLOAN, Hyun CHO, Theodore J. KUNICH, Jean-Pierre COLE, Christopher A. THOMAS, Erwin S. BUDIMAN, David L. LI, Royce CHENG, Udo HOSS
-
Patent number: 11770210Abstract: Disclosed herein are methods and systems for receiving an encoded data packet, one or more activation commands, and a communication identifier, decoding the received data packet, validating the decoded received data packet, and executing one or more routines associated with the respective one or more activation commands.Type: GrantFiled: August 12, 2019Date of Patent: September 26, 2023Assignee: ABBOTT DIABETES CARE INC.Inventors: Jeffery M. Sicurello, Mark K. Sloan
-
Patent number: 11737687Abstract: Methods, apparatuses, and systems are provided for determining whether to administer a medication dose as a single dose or whether to fractionate the single dose to be administered as at least two discrete doses. Embodiments include determining a first analyte level and a first rate of change of the analyte level; determining an initial medication dose based on one or more anticipated subsequent medication doses, the first analyte level relative to an analyte level threshold, and the first rate of change of the analyte level relative to a rate of change threshold; administering the initial medication dose; determining a second analyte level and a second rate of change of the analyte level based on subsequent analyte data; and determining a subsequent medication dose based on the second analyte level relative to the analyte level threshold and the second rate of change relative to the rate of change threshold.Type: GrantFiled: January 21, 2019Date of Patent: August 29, 2023Assignee: Abbott Diabetes Care Inc.Inventors: Mark K. Sloan, Martin J. Fennell, Daniel M. Bernstein
-
Publication number: 20230255515Abstract: Generally, methods, devices, and systems related to analyte monitoring and data logging are provided—e.g., as related to in vivo analyte monitoring devices and systems. In some aspects, methods, devices, and systems are provided that relate to enable related settings based on an expected use of an in vivo positioned sensor; logging or otherwise recording analyte levels acquired or derived—e.g., sample analyte levels more frequently than they are logged or otherwise recorded in memory; dynamically adjust the data logging frequency; randomly determine times of acquiring or storing analyte levels from the in-vivo positioned analyte sensors; and enable recording related settings when the system is operable.Type: ApplicationFiled: April 24, 2023Publication date: August 17, 2023Inventors: Mark K. SLOAN, Royce CHENG, Gary A. HAYTER, Marc B. TAUB, Mani GOPAL
-
Publication number: 20230233112Abstract: Methods, apparatuses, and systems are provided for determining whether to administer a medication dose as a single dose or whether to fractionate the single dose to be administered as at least two discrete doses. Embodiments include determining a first analyte level and a first rate of change of the analyte level; determining an initial medication dose based on one or more anticipated subsequent medication doses, the first analyte level relative to an analyte level threshold, and the first rate of change of the analyte level relative to a rate of change threshold; administering the initial medication dose; determining a second analyte level and a second rate of change of the analyte level based on subsequent analyte data; and determining a subsequent medication dose based on the second analyte level relative to the analyte level threshold and the second rate of change relative to the rate of change threshold.Type: ApplicationFiled: April 4, 2023Publication date: July 27, 2023Applicant: Abbott Diabetes Care Inc.Inventors: Mark K. SLOAN, Martin J. FENNELL, Daniel M. BERNSTEIN
-
Publication number: 20230143496Abstract: Methods of compensating for ambient temperature using temperature sensors, the method comprising: sampling at a first sampling rate, with a processor, first temperature measurements from a first temperature sensor on an on-body sensor. Then determining, with a processor, first ambient-compensated temperatures from the first temperature measurements; and determining, with a processor, final ambient-compensated temperatures by applying a correction gain or factor to the first ambient-compensated temperatures. Wherein the correction gain or factor changes value at a slower rate than the sampling rate.Type: ApplicationFiled: January 10, 2023Publication date: May 11, 2023Inventors: Gary A. HAYTER, Daniel M. BERNSTEIN, Martin J. FENNELL, Michael R. LOVE, Kenneth J. DONIGER, Songbiao ZHANG, Mark K. SLOAN, Hyun CHO, Theodore J. KUNICH, Jean-Pierre COLE, Christopher A. THOMAS, Erwin S. BUDIMAN, David L. LI, Royce CHENG, Udo HOSS
-
Publication number: 20230128038Abstract: Glucose and ketones may be dysregulated singularly or concurrently in certain physiological conditions and may be advantageously assayed together using an analyte sensor capable of detecting both analytes. Certain analyte sensors capable of dual detection may comprise a first working electrode and a second working electrode, a ketones-responsive active area disposed upon a surface of the first working electrode, a glucose-responsive active area comprising a glucose-responsive enzyme disposed upon a surface of the second working electrode, a membrane having a first portion overcoating the ketones-responsive active area and a second portion overcoating the glucose-responsive active area, in which the first portion and the second portion have different compositions. The ketones-responsive active area comprises an enzyme system comprising at least two enzymes that are capable of acting in concert to facilitate detection of ketones.Type: ApplicationFiled: December 19, 2022Publication date: April 27, 2023Applicant: Abbott Diabetes Care Inc.Inventors: Benjamin J. FELDMAN, Mark K. SLOAN, Ashwin KUMAR, Namvar KIAIE, Michael R. LOVE
-
Patent number: 11633126Abstract: Generally, methods, devices, and systems related to analyte monitoring and data logging are provided—e.g., as related to in vivo analyte monitoring devices and systems. In some aspects, methods, devices, and systems are provided that relate to enable related settings based on an expected use of an in vivo positioned sensor; logging or otherwise recording analyte levels acquired or derived—e.g., sample analyte levels more frequently than they are logged or otherwise recorded in memory; dynamically adjust the data logging frequency; randomly determine times of acquiring or storing analyte levels from the in-vivo positioned analyte sensors; and enable recording related settings when the system is operable.Type: GrantFiled: November 17, 2020Date of Patent: April 25, 2023Assignee: Abbott Diabetes Care Inc.Inventors: Mark K. Sloan, Royce Cheng, Gary A. Hayter, Marc B. Taub, Mani Gopal
-
Patent number: 11633127Abstract: Generally, methods, devices, and systems related to analyte monitoring and data logging are provided—e.g., as related to in vivo analyte monitoring devices and systems. In some aspects, methods, devices, and systems are provided that relate to enable related settings based on an expected use of an in vivo positioned sensor; logging or otherwise recording analyte levels acquired or derived—e.g., sample analyte levels more frequently than they are logged or otherwise recorded in memory; dynamically adjust the data logging frequency; randomly determine times of acquiring or storing analyte levels from the in-vivo positioned analyte sensors; and enable recording related settings when the system is operable.Type: GrantFiled: November 17, 2020Date of Patent: April 25, 2023Assignee: Abbott Diabetes Care Inc.Inventors: Mark K. Sloan, Royce Cheng, Gary A. Hayter, Marc B. Taub, Mani Gopal
-
Publication number: 20230119512Abstract: Glucose and ketones may be dysregulated singularly or concurrently in certain physiological conditions and may be advantageously assayed together using an analyte sensor capable of detecting both analytes. Certain analyte sensors capable of dual detection may comprise a first working electrode and a second working electrode, a ketones-responsive active area disposed upon a surface of the first working electrode, a glucose-responsive active area comprising a glucose-responsive enzyme disposed upon a surface of the second working electrode, a membrane having a first portion overcoating the ketones-responsive active area and a second portion overcoating the glucose-responsive active area, in which the first portion and the second portion have different compositions. The ketones-responsive active area comprises an enzyme system comprising at least two enzymes that are capable of acting in concert to facilitate detection of ketones.Type: ApplicationFiled: December 20, 2022Publication date: April 20, 2023Applicant: Abbott Diabetes Care Inc.Inventors: Benjamin J. FELDMAN, Mark K. SLOAN, Ashwin KUMAR, Namvar KIAIE, Michael R. LOVE
-
Publication number: 20230123384Abstract: Glucose and ketones may be dysregulated singularly or concurrently in certain physiological conditions and may be advantageously assayed together using an analyte sensor capable of detecting both analytes. Certain analyte sensors capable of dual detection may comprise a first working electrode and a second working electrode, a ketones-responsive active area disposed upon a surface of the first working electrode, a glucose-responsive active area comprising a glucose-responsive enzyme disposed upon a surface of the second working electrode, a membrane having a first portion overcoating the ketones-responsive active area and a second portion overcoating the glucose-responsive active area, in which the first portion and the second portion have different compositions. The ketones-responsive active area comprises an enzyme system comprising at least two enzymes that are capable of acting in concert to facilitate detection of ketones.Type: ApplicationFiled: December 20, 2022Publication date: April 20, 2023Applicant: Abbott Diabetes Care Inc.Inventors: Benjamin J. FELDMAN, Mark K. SLOAN, Ashwin KUMAR, Namvar KIAIE, Michael R. LOVE
-
Publication number: 20230118818Abstract: Glucose and ketones may be dysregulated singularly or concurrently in certain physiological conditions and may be advantageously assayed together using an analyte sensor capable of detecting both analytes. Certain analyte sensors capable of dual detection may comprise a first working electrode and a second working electrode, a ketones-responsive active area disposed upon a surface of the first working electrode, a glucose-responsive active area comprising a glucose-responsive enzyme disposed upon a surface of the second working electrode, a membrane having a first portion overcoating the ketones-responsive active area and a second portion overcoating the glucose-responsive active area, in which the first portion and the second portion have different compositions. The ketones-responsive active area comprises an enzyme system comprising at least two enzymes that are capable of acting in concert to facilitate detection of ketones.Type: ApplicationFiled: December 20, 2022Publication date: April 20, 2023Applicant: Abbott Diabetes Care Inc.Inventors: Benjamin J. FELDMAN, Mark K. SLOAN, Ashwin KUMAR, Namvar KIAIE, Michael R. LOVE
-
Publication number: 20230121367Abstract: Glucose and ketones may be dysregulated singularly or concurrently in certain physiological conditions and may be advantageously assayed together using an analyte sensor capable of detecting both analytes. Certain analyte sensors capable of dual detection may comprise a first working electrode and a second working electrode, a ketones-responsive active area disposed upon a surface of the first working electrode, a glucose-responsive active area comprising a glucose-responsive enzyme disposed upon a surface of the second working electrode, a membrane having a first portion overcoating the ketones-responsive active area and a second portion overcoating the glucose-responsive active area, in which the first portion and the second portion have different compositions. The ketones-responsive active area comprises an enzyme system comprising at least two enzymes that are capable of acting in concert to facilitate detection of ketones.Type: ApplicationFiled: December 19, 2022Publication date: April 20, 2023Applicant: Abbott Diabetes Care Inc.Inventors: Benjamin J. FELDMAN, Mark K. SLOAN, Ashwin KUMAR, Namvar KIAIE, Michael R. LOVE
-
Publication number: 20230121101Abstract: Glucose and ketones may be dysregulated singularly or concurrently in certain physiological conditions and may be advantageously assayed together using an analyte sensor capable of detecting both analytes. Certain analyte sensors capable of dual detection may comprise a first working electrode and a second working electrode, a ketones-responsive active area disposed upon a surface of the first working electrode, a glucose-responsive active area comprising a glucose-responsive enzyme disposed upon a surface of the second working electrode, a membrane having a first portion overcoating the ketones-responsive active area and a second portion overcoating the glucose-responsive active area, in which the first portion and the second portion have different compositions. The ketones-responsive active area comprises an enzyme system comprising at least two enzymes that are capable of acting in concert to facilitate detection of ketones.Type: ApplicationFiled: December 20, 2022Publication date: April 20, 2023Applicant: Abbott Diabetes Care Inc.Inventors: Benjamin J. FELDMAN, Mark K. SLOAN, Ashwin KUMAR, Namvar KIAIE, Michael R. LOVE
-
Publication number: 20230122702Abstract: Glucose and ketones may be dysregulated singularly or concurrently in certain physiological conditions and may be advantageously assayed together using an analyte sensor capable of detecting both analytes. Certain analyte sensors capable of dual detection may comprise a first working electrode and a second working electrode, a ketones-responsive active area disposed upon a surface of the first working electrode, a glucose-responsive active area comprising a glucose-responsive enzyme disposed upon a surface of the second working electrode, a membrane having a first portion overcoating the ketones-responsive active area and a second portion overcoating the glucose-responsive active area, in which the first portion and the second portion have different compositions. The ketones-responsive active area comprises an enzyme system comprising at least two enzymes that are capable of acting in concert to facilitate detection of ketones.Type: ApplicationFiled: December 20, 2022Publication date: April 20, 2023Applicant: Abbott Diabetes Care Inc.Inventors: Benjamin J. FELDMAN, Mark K. SLOAN, Ashwin KUMAR, Namvar KIAIE, Michael R. LOVE
-
Publication number: 20230121769Abstract: Glucose and ketones may be dysregulated singularly or concurrently in certain physiological conditions and may be advantageously assayed together using an analyte sensor capable of detecting both analytes. Certain analyte sensors capable of dual detection may comprise a first working electrode and a second working electrode, a ketones-responsive active area disposed upon a surface of the first working electrode, a glucose-responsive active area comprising a glucose-responsive enzyme disposed upon a surface of the second working electrode, a membrane having a first portion overcoating the ketones-responsive active area and a second portion overcoating the glucose-responsive active area, in which the first portion and the second portion have different compositions. The ketones-responsive active area comprises an enzyme system comprising at least two enzymes that are capable of acting in concert to facilitate detection of ketones.Type: ApplicationFiled: December 19, 2022Publication date: April 20, 2023Applicant: Abbott Diabetes Care Inc.Inventors: Benjamin J. FELDMAN, Mark K. SLOAN, Ashwin KUMAR, Namvar KIAIE, Michael R. LOVE
-
Patent number: 11586273Abstract: Methods and articles of manufacture for hosting a safety critical application on an uncontrolled data processing device are provided. Various combinations of installation, functional, host integrity, coexistence, interoperability, power management, and environment checks are performed at various times to determine if the safety critical application operates properly on the device. The operation of the SCA on the UDPD may be controlled accordingly.Type: GrantFiled: August 4, 2021Date of Patent: February 21, 2023Assignee: Abbott Diabetes Care Inc.Inventors: Daniel M. Bernstein, Saeed Nekoomaram, Mark K. Sloan